Intelligence · Clinical Development
Pipeline search results
Programs matching “docetaxel” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 38 pipeline programs matching "docetaxel" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Docetaxel + Sunitinib
Samsung Bioepis NL B.V.
Advanced Gastric Cancer
1 trial -
Docetaxel, Reolysin and Prednisone
ONCOLYTICS BIOTECH INC
Prostate Cancer
1 trial -
Gemcitabine , Docetaxel
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcoma
1 trial -
LOTS-GC-01
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
NDV01 intravesical controlled release formulation of gemcitabine and docetaxel
RELMADA THERAPEUTICS, INC.
Non Muscle Invasive Bladder Cancer
1 trial -
docetaxel
Sanofi Pasteur
Nasopharyngeal Neoplasms
1 trial -
docetaxel and ketoconazole
Hospital Authority, Hong Kong
Metastatic Breast Cancer
1 trial -
docetaxel+CDDP
Solid Biosciences
Head and Neck Squamous Cell Carcinoma
1 trial -
doxorubicin, docetaxel
Hospital Authority, Hong Kong
Metastatic Breast Cancer
1 trial -
Docetaxel
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Docetaxel
Mereo BioPharma Group plc
Solid Tumors
1 trial -
docetaxel
Hoffmann-La Roche
Breast Cancer
2 trials -
Docetaxel
The First People's Hospital of Lianyungang
Esophageal Neoplasms
1 trial -
Docetaxel
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.